Orange Book product · Generic (ANDA)
KANTREX
KANAMYCIN SULFATE
At a glance
Sep 21, 1984
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 21, 1984
42 yr 4 mo ago
Today
Pharmaceutical detail
Active ingredient
KANAMYCIN SULFATE
Strength
EQ 1GM BASE/3ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
ANDA 062564
Product number
003
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of KANAMYCIN SULFATE
- 2002KANAMYCIN SULFATEGeneric (ANDA)
ANDA 065111 · FRESENIUS KABI USA
- 1992KANAMYCIN SULFATEGeneric (ANDA)
ANDA 063025 · LOCH
- 1992KANAMYCIN SULFATEGeneric (ANDA)
ANDA 063021 · LOCH
- 1992KANAMYCIN SULFATEGeneric (ANDA)
ANDA 063022 · LOCH
- 1989KANAMYCIN SULFATEGeneric (ANDA)
ANDA 063092 · WARNER CHILCOTT
- 1987KANAMYCIN SULFATEGeneric (ANDA)
ANDA 062669 · PHARMAFAIR
- 1987KANAMYCIN SULFATEGeneric (ANDA)
ANDA 062668 · PHARMAFAIR
- 1987KANAMYCIN SULFATEGeneric (ANDA)
ANDA 062672 · PHARMAFAIR
- 1987KANTREXGeneric (ANDA)
ANDA 062726 · APOTHECON
- 1986KANAMYCIN SULFATEGeneric (ANDA)
ANDA 062605 · SOLOPAK
- 1985KANAMYCIN SULFATEGeneric (ANDA)
ANDA 062520 · WATSON LABS
- 1984KANAMYCIN SULFATEGeneric (ANDA)
ANDA 062504 · ABRAXIS PHARM
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
